RhumbLine Advisers’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,493	Closed	-$43.5K	–	4293
2025 Q1	$43.5K	Buy	14,493 +1,614	+13%	+$4.84K	﹤0.01%	3606
2024 Q4	$130K	Sell	12,879 -1,950	-13%	-$19.7K	﹤0.01%	3394
2024 Q3	$229K	Buy	+14,829	New	+$229K	﹤0.01%	3169